A Case for Risk-adapted Management of Low-grade Bladder Tumors

Eur Urol Oncol. 2020 Feb;3(1):128-129. doi: 10.1016/j.euo.2019.09.007. Epub 2019 Oct 20.

Abstract

Management of low-grade bladder cancer should focus on minimizing morbidity and costs given the excellent oncologic outcomes.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Neoplasm Grading
  • Risk Factors
  • Urinary Bladder Neoplasms / therapy*